The Promise of Targeting Macrophages in Cancer Therapy
Reads0
Chats0
TLDR
The data clearly support the validity of clinical testing of combining targeting TAMs with conventional therapy and the many preclinical studies that have shown that the response of tumors to irradiation and anticancer drugs can be improved, sometimes markedly so, by depleting TAMs from tumors or by suppressing their polarization from an M1 to an M2 phenotype.Abstract:
Cancer therapy has developed around the concept of killing, or stopping the growth of, the cancer cells. Molecularly targeted therapy is the modern expression of this paradigm. Increasingly, however, the realization that the cancer has co-opted the normal cells of the stroma for its own survival has led to the concept that the tumor microenvironment (TME) could be targeted for effective therapy. In this Review we outline the importance of tumor associated macrophages (TAMs), a major component of the TME, in the response of tumors to cancer therapy. We discuss the normal role of macrophages in wound healing, the major phenotypes of TAMs and their role in blunting the efficacy to cancer treatment by radiation and anticancer drugs both by promoting tumor angiogenesis and by suppressing antitumor immunity. Finally we review the many preclinical studies that have shown that the response of tumors to irradiation and anticancer drugs can be improved, sometimes markedly so, by depleting TAMs from tumors or by suppressing their polarization from an M1 to an M2 phenotype. The data clearly support the validity of clinical testing of combining targeting TAMs with conventional therapy.read more
Citations
More filters
Journal ArticleDOI
Tumor microenvironment as a therapeutic target in cancer
TL;DR: Current progress in targeting the tumor microenvironment in both drug development and clinical trials is summarized and challenges are highlighted to achieve therapeutic efficacy and strategies to intervene in the pro-tumor microenvironment are discussed.
Journal ArticleDOI
Exosomes Released from Tumor-Associated Macrophages Transfer miRNAs That Induce a Treg/Th17 Cell Imbalance in Epithelial Ovarian Cancer.
Jieru Zhou,Xiaoduan Li,Xiaoli Wu,Ting Zhang,Qinyi Zhu,Xinjing Wang,H. W. Wang,Kai Wang,Yingying Lin,Xipeng Wang +9 more
TL;DR: Results indicate that exosomes mediate the interaction between TAMs and T cells, generating an immune-suppressive microenvironment that facilitates EOC progression and metastasis, and suggest that targeting these exosome or their associated miRNAs might pave the way for the development of novel treatments for EOC.
Journal ArticleDOI
Stromal biology and therapy in pancreatic cancer : ready for clinical translation?
Albrecht Neesse,Christian Bauer,Daniel Öhlund,Matthias Lauth,Malte Buchholz,Patrick Michl,David A. Tuveson,Thomas M. Gress +7 more
TL;DR: An update of the most recent findings in the tumour microenvironment in PDA is provided and their translational and clinical implications for basic scientists and clinicians alike are discussed.
Journal ArticleDOI
UVB-Induced Tumor Heterogeneity Diminishes Immune Response in Melanoma
Yochai Wolf,Osnat Bartok,Sushant Patkar,Gitit Bar Eli,Sapir Cohen,Kevin Litchfield,Ronen Levy,Alejandro Jiménez-Sánchez,Sophie Trabish,Joo Sang Lee,Hiren Karathia,Eilon Barnea,Chi-Ping Day,Einat Cinnamon,Ilan Stein,Adam Solomon,Lital Bitton,Eva Pérez-Guijarro,Tania Dubovik,Shai S. Shen-Orr,Martin L. Miller,Glenn Merlino,Yishai Levin,Eli Pikarsky,Lea Eisenbach,Arie Admon,Charles Swanton,Eytan Ruppin,Yardena Samuels +28 more
TL;DR: The analysis of melanoma patient tumor data recapitulates the results in terms of overall survival and response to immune checkpoint therapy and highlights the importance of clonal mutations in robust immune surveillance and the need to quantify patient ITH to determine the response to checkpoint blockade.
Journal ArticleDOI
Macrophages derived exosomes deliver miR-223 to epithelial ovarian cancer cells to elicit a chemoresistant phenotype.
Xiaolan Zhu,Huiling Shen,Xinming Yin,Meiling Yang,Hong Wei,Qi Chen,Fan Feng,Yueqin Liu,Wenlin Xu,Yuefeng Li +9 more
TL;DR: A functional assay revealed that exosomal miR-223 derived from macrophages promoted the drug resistance of EOC cells via the PTEN-PI3K/AKT pathway both in vivo and in vitro.
References
More filters
Journal ArticleDOI
Immune-mediated mechanisms influencing the efficacy of anticancer therapies
TL;DR: The impact of innate and adaptive immune cells on the success of anticancer therapy is discussed and the opportunities to exploit host immune responses to boost tumor clearing are examined.
Journal ArticleDOI
JNJ-28312141, a novel orally active colony-stimulating factor-1 receptor/FMS-related receptor tyrosine kinase-3 receptor tyrosine kinase inhibitor with potential utility in solid tumors, bone metastases, and acute myeloid leukemia
Carl L. Manthey,Dana L. Johnson,Carl R. Illig,Tuman Robert W,Zhao Zhou,Judith Baker,Margery A. Chaikin,Robert R. Donatelli,Carol F. Franks,Lee Zeng,Carl Crysler,Yanmin Chen,Edward J. Yurkow,Lisa Boczon,Sanath K. Meegalla,Kenneth J. Wilson,Mark J. Wall,Jinsheng Chen,Shelley K. Ballentine,Heidi Ott,Baumann Christian Andrew,Danielle Lawrence,Bruce E. Tomczuk,Christopher J. Molloy +23 more
TL;DR: This novel CSF-1R/FLT3 inhibitor represents a new agent with potential therapeutic activity in acute myeloid leukemia and in settings where CSf-1–dependent macrophages and osteoclasts contribute to tumor growth and skeletal events.
Journal ArticleDOI
Tumor hypoxia enhances Non-Small Cell Lung Cancer metastasis by selectively promoting macrophage M2 polarization through the activation of ERK signaling.
Jun Zhang,Ji Cao,Shenglin Ma,Rong Dong,Wen Meng,Meidan Ying,Qinjie Weng,Zibo Chen,Jian Ma,Qingxia Fang,Qiaojun He,Bo Yang +11 more
TL;DR: The results suggest that intermittent hypoxia significantly promotes the metastasis of Lewis lung carcinoma (LLC), accompanied with more CD209+ macrophages infiltrated in primary tumor tissue, andHypoxia and IL-6 cooperate to enhance the LLC metastasis both in vitro and in vivo.
Journal ArticleDOI
Intratumoral Delivery of IL-21 Overcomes Anti-Her2/Neu Resistance through Shifting Tumor-Associated Macrophages from M2 to M1 Phenotype
Meng Xu,Mingyue Liu,Xuexiang Du,Sirui Li,Hang Li,Xiaozhu Li,Ying Li,Yang Wang,Zhihai Qin,Yang Xin Fu,Yang Xin Fu,Shengdian Wang +11 more
TL;DR: This study demonstrates that tumor progression is highly associated with TAMs with immune-suppressive M2 phenotypes, and deletion of TAMs markedly enhanced the therapeutic effects of anti-Her2/neu Ab in a HER2/NEu-dependent breast cancer cell TUBO model, and offers a therapeutic strategy to modulate the tumor microenvironment to overcome tumor-extrinsic resistance.
Journal ArticleDOI
High infiltration of tumor-associated macrophages is associated with a poor response to chemotherapy and poor prognosis of patients undergoing neoadjuvant chemotherapy for esophageal cancer.
Keijiro Sugimura,Hiroshi Miyata,Koji Tanaka,Tsuyoshi Takahashi,Yukinori Kurokawa,Makoto Yamasaki,Kiyokazu Nakajima,Shuji Takiguchi,Masaki Mori,Yuichiro Doki +9 more
TL;DR: The aim of this study is to examine whether TAMs, especially M2 macrophages, are associated with the tumor response to chemotherapy with esophageal cancers.
Related Papers (5)
Macrophage Diversity Enhances Tumor Progression and Metastasis
Bin-Zhi Qian,Jeffrey W. Pollard +1 more